Epigenomics AG - Company Profile
Powered by 
All the sales intelligence you need on Epigenomics AG in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Epigenomics AG fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Epigenomics AG.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Epigenomics AG (Epigenomics) is a molecular diagnostics company which develops and commercializes in-vitro diagnostic (IVD) tests for screening, early detection and diagnosis of cancer. Its lead product, Epi proColon is a blood-based test for rapid detection of colorectal cancer; and Epi proLung, a validating test for the diagnosis of lung cancer. It’s molecular diagnostic products are based on its proprietary methylation technology, which is based on a biological phenomenon called DNA methylation. The company also offers Epi BiSKit, a pre-analytical kit for the preparation of bisulfite-converted DNA, and HCCBloodTest for the detection of hepatocellular carcinoma (HCC). Epigenomics is headquartered in Berlin, Germany.
Epigenomics AG premium industry data and analytics
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer